Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2009 1
2010 2
2012 1
2013 2
2014 1
2015 1
2016 2
2017 2
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. ...
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of ed …
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators. Pulido T, et al. N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917. N Engl J Med. 2013. PMID: 23984728 Free article. Clinical Trial.
BACKGROUND: Current therapies for pulmonary arterial hypertension have been adopted on the basis of short-term trials with exercise capacity as the primary end point. We assessed the efficacy of macitentan, a new dual endothelin-receptor antagonist, using a primary end poi …
BACKGROUND: Current therapies for pulmonary arterial hypertension have been adopted on the basis of short-term trials with exercise c …
Prognosis of patients with previous myocardial infarction, coronary slow flow, and normal coronary angiogram.
Zivanic A, Stankovic I, Ilic I, Putnikovic B, Neskovic AN. Zivanic A, et al. Among authors: putnikovic b. Herz. 2020 Dec;45(Suppl 1):88-94. doi: 10.1007/s00059-019-4817-4. Epub 2019 Jun 11. Herz. 2020. PMID: 31187194 English.
Little is known about whether a history of previous coronary events affects the long-term survival in this population. In this retrospective, observational study, we assessed the possible association of a previous coronary event and long-term prognosis in patients w …
Little is known about whether a history of previous coronary events affects the long-term survival in this population. In this retros …
[Takotsubo cardiomyopathy: report of the first case series in Serbia and review of the literature].
Putniković B, Cvorović V, Panić M, Milicević P, Vojinović-Maglić G, Nesković AN. Putniković B, et al. Med Pregl. 2010 Jan-Feb;63(1-2):75-81. doi: 10.2298/mpns1002075p. Med Pregl. 2010. PMID: 20873314 Review. Serbian.
Therapy is empiric and directed towards supportive measures against cardiogenic shock, acute heart failure, dysrhythmias. In-hospital mortality rate is less than 1%, but long-term prognosis is still unknown. In addition to the review of the literature on takotsubo cardiomy …
Therapy is empiric and directed towards supportive measures against cardiogenic shock, acute heart failure, dysrhythmias. In-hospital mortal …
Androgen status in non-diabetic elderly men with heart failure.
Loncar G, Bozic B, Neskovic AN, Cvetinovic N, Lainscak M, Prodanovic N, Dungen HD, von Haehling S, Radojicic Z, Trippel T, Putnikovic B, Markovic-Nikolic N, Popovic V. Loncar G, et al. Among authors: putnikovic b. Aging Male. 2017 Dec;20(4):215-224. doi: 10.1080/13685538.2017.1350155. Epub 2017 Jul 11. Aging Male. 2017. PMID: 28696825
Additionally, we investigated its associations with body composition and long-term survival. METHODS: Seventy three non-diabetic men with HF and 20 healthy men aged over 55 years were studied. ...CONCLUSIONS: In non-diabetic men with HF, androgen status is not altered and …
Additionally, we investigated its associations with body composition and long-term survival. METHODS: Seventy three non-diabetic men …
Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure.
Loncar G, Bozic B, Cvetinovic N, Dungen HD, Lainscak M, von Haehling S, Doehner W, Radojicic Z, Putnikovic B, Trippel T, Popovic V. Loncar G, et al. Among authors: putnikovic b. J Endocrinol Invest. 2017 Mar;40(3):297-304. doi: 10.1007/s40618-016-0561-2. Epub 2016 Oct 13. J Endocrinol Invest. 2017. PMID: 27738907
A total of 41 (56 %) patients died within 6 years of follow-up. Kaplan-Meier survival analysis showed impaired long-term survival in patients with SHPT versus patients with normal PTH (p = 0.009). ...
A total of 41 (56 %) patients died within 6 years of follow-up. Kaplan-Meier survival analysis showed impaired long-term survival in …
Short QT interval is unreliable marker of anabolic androgenic steroid abuse in competitive athletes.
Djordjević V, Stanković I, Stipac AV, Putniković B, Nesković AN. Djordjević V, et al. Among authors: putnikovic b. Srp Arh Celok Lek. 2012 Nov-Dec;140(11-12):711-6. Srp Arh Celok Lek. 2012. PMID: 23350243 Free article.
METHODS: We recruited 22 elite male athletes involved in long-term strength or endurance training and 20 sedentary controls. All elite SA reported AAS abuse, whereas EA and controls were AAS-free. ...
METHODS: We recruited 22 elite male athletes involved in long-term strength or endurance training and 20 sedentary controls. All elit …
The impact of anabolic androgenic steroids abuse and type of training on left ventricular remodeling and function in competitive athletes.
Ilić I, Djordjević V, Stanković I, Vlahović-Stipac A, Putniković B, Babić R, Nesković AN. Ilić I, et al. Among authors: putnikovic b. Vojnosanit Pregl. 2014 Apr;71(4):383-9. doi: 10.2298/vsp130504046i. Vojnosanit Pregl. 2014. PMID: 24783419
BACKGROUND/AIM: Long-term intensive training is associated with distinctive cardiac adaptations which are known as athlete's heart. ...CONCLUSIONS: There is no evidence that LV ejection fraction in elite athletes is altered by either type of training or AAS misuse. Long- …
BACKGROUND/AIM: Long-term intensive training is associated with distinctive cardiac adaptations which are known as athlete's heart. . …
Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.
Marcun R, Stankovic I, Vidakovic R, Farkas J, Kadivec S, Putnikovic B, Ilic I, Neskovic AN, Lainscak M. Marcun R, et al. Among authors: putnikovic b. Intern Emerg Med. 2016 Jun;11(4):519-27. doi: 10.1007/s11739-015-1319-0. Epub 2015 Sep 30. Intern Emerg Med. 2016. PMID: 26423072
I-III, HR 2.37, CI 1.23-4.59) and N-terminal pro B-type natriuretic peptide (NT-proBNP) levels (HR 2.79, CI 1.12-6.98) were independent predictors of long-term survival. HFpEF is present in one-fifth of patients with exacerbated COPD. ...
I-III, HR 2.37, CI 1.23-4.59) and N-terminal pro B-type natriuretic peptide (NT-proBNP) levels (HR 2.79, CI 1.12-6.98) were independent pred …
Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis.
Vlahović A, Nesković AN, Dekleva M, Putniković B, Popović ZB, Otasević P, Ostojić M. Vlahović A, et al. Among authors: putnikovic b. Am Heart J. 2004 Jul;148(1):e1. doi: 10.1016/j.ahj.2004.02.009. Am Heart J. 2004. PMID: 15215810 Clinical Trial.
However, there are no data on the effects of hyperbaric oxygen on diastolic function after myocardial infarction. METHODS: To assess acute and short-term effects of hyperbaric oxygen on left ventricular chamber stiffness, we studied 74 consecutive patients with first acute …
However, there are no data on the effects of hyperbaric oxygen on diastolic function after myocardial infarction. METHODS: To assess acute a …
12 results